Comparing NBD vs. BD-NI, the CRP and ESR decreased in 62.5% of NBD patients and 58.0% of BD-NI patients, which is relatively similar, suggesting that treatment effectively reduced inflammation in both groups [35]. This evidence concerns the gene CRP and Behcet disease.